Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 September;51(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 September;51(3):260-71

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

REVIEWS  ADVANCES IN PET - PART I


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 September;51(3):260-71

language: English

PET in genitourinary tract cancers

Fanti S. 1, Nanni C. 1, Ambrosini V. 1, Gross M. D. 2, Rubello D. 3, Farsad M. 1

1 Unit of Nuclear Medicine S.Orsola-Malpighi Polyclinic, Bologna, Italy
2 Nuclear Medicine Service, Veterans Affairs Hospital Ann Arbor, MI, USA
3 Unit of Nuclear Medicine S. Maria della Misericordia Rovigo Hospital, Rovigo, Italy


FULL TEXT  


Genitourinary (GU) tract cancers comprise a variety of tumors, which includes some of the most common malignancies in men and women. As a result of the importance of GU neoplasms and the success of positron emission tomography (PET) in imaging and staging cancer, PET with fluorodeoxyglucose (FDG) has been used to depict and stage ovarian, cervical and testicular cancers. The early success of FDG PET in imaging GU tumors is tempered by the fact that some neoplasms of GU origin do not accumulate sufficient FDG for successful imaging. As a result, alternative agents, such as [11C]choline and [11C]acetate, have been used to image prostate cancer and may have utility in bladder cancer, while other PET agents are currently under active evaluation for this and other GU neoplasms. In this paper, we review the current literature and our experience in role of PET in imaging cancers of the GU tract.

top of page

Publication History

Cite this article as

Corresponding author e-mail